Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Alcon AG (ALC) – Alcon AG Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ALC trades at $77.56, up 3.93% today, with a bearish technical signal but strong fundamentals including revenue growth to $9.91B in 2024 and net income of $1.02B. Recent product launches like Clareon TruPlus IOLs at ASCRS 2026 highlight innovation, though Q4 2025 earnings missed estimates. Cash flow from operations improved to $2.08B in 2024, supporting financial stability.
Outlook is mixed: analyst consensus is bullish with a $92.20 price target, but risks include legal challenges from Sight Sciences patent case and integration issues from terminated mergers. The stock offers growth potential from eyecare demand, balanced by execution and competitive risks.
Read full analysis

Key Stats

  • Market Cap
    $37.74B
  • Sector
    Health
  • 3M Drawdown
    -15.88%
  • Enterprise Value
    $41.58B
  • Dividend Yield
    0.46%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    69 days
$76.95
52W Low: $72.05
10 Oct 2025
52W High: $98.3
02 May 2025

Alcon AG (ALC) is currently valued at a market capitalization of $37.74B, with an enterprise value of $41.58B. Over the past 52 weeks, Alcon AG has traded between a low of $72.05 and a high of $98.3, highlighting its annual price range. Over the past three months, Alcon AG has recorded a drawdown of -15.88%, reflecting recent price volatility. Alcon AG offers a dividend yield of 0.46%, with the most recent dividend of $0.28 paid on 14 May 25. On average, investors hold Alcon AG for approximately 69 days, indicating typical investor behavior on the platform.

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.


Technical Indicators
|
|
|
Overall Summary
Bearish (13)Neutral (9)Bullish (5)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $37.74B
  • Sector
    Health
  • 3M Drawdown
    -15.88%
  • Enterprise Value
    $41.58B
  • Dividend Yield
    0.46%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    69 days
$76.95
52W Low: $72.05
10 Oct 2025
52W High: $98.3
02 May 2025

Alcon AG (ALC) is currently valued at a market capitalization of $37.74B, with an enterprise value of $41.58B. Over the past 52 weeks, Alcon AG has traded between a low of $72.05 and a high of $98.3, highlighting its annual price range. Over the past three months, Alcon AG has recorded a drawdown of -15.88%, reflecting recent price volatility. Alcon AG offers a dividend yield of 0.46%, with the most recent dividend of $0.28 paid on 14 May 25. On average, investors hold Alcon AG for approximately 69 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!